documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
20 rows where docket_id = "FDA-2000-D-0187" and posted_year = 2020 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2000-D-0187-0031 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 4 Mace KE et al - MMWR 2017 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:02:06Z | 0 | 0 | 09000064846f6952 | |||
| FDA-2000-D-0187-0030 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 3 - OBrien SF - Transfusion medicine reviews 2015 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:01:54Z | 0 | 0 | 09000064846f6951 | |||
| FDA-2000-D-0187-0043 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 15 FDA BPAC Transcripts 111609 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:05:11Z | 0 | 0 | 09000064846f69b0 | |||
| FDA-2000-D-0187-0026 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Other | Guidance | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T04:00:00Z | 2022-12-08T15:47:25Z | 0 | 0 | 09000064846f6586 | ||
| FDA-2000-D-0187-0027 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Reference List Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:00:39Z | 0 | 0 | 09000064846f658e | |||
| FDA-2000-D-0187-0039 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 11 Doolan D L et al Acquired immunity to malaria Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:04:15Z | 0 | 0 | 09000064846f69ac | |||
| FDA-2000-D-0187-0033 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 5 - Mace KE et al - MMWR 2018Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:02:37Z | 0 | 0 | 09000064846f697e | |||
| FDA-2000-D-0187-0036 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 8 - Reesink et al - Transfusion 2010 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:23Z | 0 | 0 | 09000064846f6981 | |||
| FDA-2000-D-0187-0041 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 13 FDA Workshop Testing for malarial infections in blood donors July 12 2006 FDA Blood Products Advisory Committee Testing for malarial infections in blood donors July 13 2006 | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:04:50Z | 0 | 0 | 09000064846f69ae | |||
| FDA-2000-D-0187-0029 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 2 - Mungai M et al - NEJM 2001 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:01:44Z | 0 | 0 | 09000064846f6950 | |||
| FDA-2000-D-0187-0035 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 7 Spencer B et al Risk for malaria in United States donors deferred for travel to malaria endemic areas Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:14Z | 0 | 0 | 09000064846f6980 | |||
| FDA-2000-D-0187-0032 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 5 - Mace KE et al - MMWR 2018 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:02:16Z | 0 | 0 | 09000064846f6953 | |||
| FDA-2000-D-0187-0034 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 6 - Mace KE et al - MMWR 2019 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:00Z | 0 | 0 | 09000064846f697f | |||
| FDA-2000-D-0187-0037 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 9 - Spenser B et al - Transfusion Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:35Z | 0 | 0 | 09000064846f6982 | |||
| FDA-2000-D-0187-0042 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 14 FDA Blood Products Advisory Committee - Sept 2008 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:05:00Z | 0 | 0 | 09000064846f69af | |||
| FDA-2000-D-0187-0038 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 10 Liljander A et al Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum in-1 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:03:48Z | 0 | 0 | 09000064846f6983 | |||
| FDA-2000-D-0187-0028 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 1 - Katz LM & Spenser BR - AABB Press 2019 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:00:59Z | 0 | 0 | 09000064846f694f | |||
| FDA-2000-D-0187-0025 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Revised Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry; Availability | Notice | Notice of Availability | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T04:00:00Z | 2020-06-17T13:13:25Z | 2020-13066 | 0 | 0 | 09000064846f5e19 | |
| FDA-2000-D-0187-0040 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Ref 12 - Nguyen ML et al - Transfusion 2013 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria | Supporting & Related Material | Background Material | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T15:04:26Z | 0 | 0 | 09000064846f69ad | |||
| FDA-2000-D-0187-0024 | FDA | Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 | Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Guidance for Industry | Other | Guidance | 2020-04-03T04:00:00Z | 2020 | 4 | 2020-04-03T04:00:00Z | 2024-11-06T23:34:52Z | 1 | 0 | 0900006484485685 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);